Form 4: Ligand Pharmaceuticals CLO & Secretary Andrew Reardon Acquires Additional Shares

Ligand Pharmaceuticals' Chief Legal Officer and Secretary, Andrew Reardon, acquired 233 shares of common stock at $91.0775 per share through the company's Employee Stock Purchase Plan.

Summary

• Andrew Reardon, Chief Legal Officer and Secretary of Ligand Pharmaceuticals Inc. (LGND), acquired 233 shares of common stock.
• The acquisition occurred on June 30, 2025, at a price of $91.0775 per share.
• These shares were acquired under the Ligand Employee Stock Purchase Plan (ESPP).
• Following this transaction, Andrew Reardon beneficially owns 32,136 shares of Ligand Pharmaceuticals common stock directly.
• The transaction is exempt under SEC Rules 16b-3(d) and 16b-3(c).

Sentiment

Score: 8

Explanation: The acquisition of shares by a high-ranking officer, especially through an employee stock purchase plan, is a strong positive signal of management's confidence in the company's valuation and future prospects.

Positives

• Insider acquisition of shares, indicating management's confidence in the company's future prospects.
• Shares acquired through an Employee Stock Purchase Plan (ESPP), which often allows employees to purchase shares at a discount, aligning employee interests with shareholder interests.

Future Outlook

NA

Industry Context

This transaction reflects an individual insider's investment decision within the biotechnology and pharmaceutical industry, where insider confidence can be a signal of perceived value or future growth.

Comparison to Industry Standards

• Insider purchases, particularly through employee plans, are common across industries.
• While the specific price and volume are unique to this transaction, the act of an officer increasing their stake is generally viewed positively, aligning with practices in other publicly traded companies where management invests alongside shareholders.

Related Party Transactions

• Acquisition of 233 shares of common stock by Andrew Reardon through the Ligand Employee Stock Purchase Plan, which is a common form of related party transaction between an employee and the company.

Stakeholder Impact

• Shareholders: The transaction signals management's confidence, potentially boosting investor sentiment.
• Employees: The Employee Stock Purchase Plan encourages employee ownership and alignment with company performance.

Key Dates

Recommendation

Keywords

Ligand Pharmaceuticals, LGND, Andrew Reardon, Insider Trading, SEC Form 4, Stock Purchase, Employee Stock Purchase Plan, ESPP, Common Stock, Officer Transaction